- +120.6% price growth over the last year
- Strong return on equity of 326.8%
- Bullish trend confirmed on both short and long timeframes
The Oncology Institute, Inc. stock price up 2.94% on Wednesday
(Updated on Jun 17, 2026)
The The Oncology Institute, Inc. stock price gained 2.94% on the last trading day (Wednesday, 17th Jun 2026), rising from $5.10 to $5.25. During the last trading day the stock fluctuated 7.39% from a day low at $5.12 to a day high of $5.50. The price has risen in 6 of the last 10 days and is up by 24.11% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 687 thousand more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $10.13 million.
The stock lies in the upper part of a wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $5.42 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 69.03% during the next 3 months and, with a 90% probability hold a price between $7.69 and $9.15 at the end of this 3-month period.
TOI Signals & Forecast
The The Oncology Institute, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $5.09 and $4.44. A breakdown below any of these levels will issue sell signals. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, June 12, 2026, and so far it has fallen -1.13%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for The Oncology Institute, Inc. stock
On the downside, the stock finds support just below today's level from accumulated volume at $4.87 and $4.59. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, The Oncology Institute, Inc. finds support just below today's level at $4.87. If this is broken, then the next support from accumulated volume will be at $4.59 and $4.08.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.379 between high and low, or 7.39%. For the last week, the stock has had daily average volatility of 8.14%.
Our recommended stop-loss: $5.03 (-4.20%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 3 days ago.)
Trading Expectations (TOI) For The Upcoming Trading Day Of Thursday 18th
For the upcoming trading day on Thursday, 18th we expect The Oncology Institute, Inc. to open at $5.29, and during the day (based on 14 day Average True Range), to move between $5.07 and $5.43, which gives a possible trading interval of +/-$0.352 (+/-6.94%) up or down from last closing price. If The Oncology Institute, Inc. takes out the full calculated possible swing range there will be an estimated 6.94% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $5.31 (1.14%) than the support at $4.87 (7.24%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is The Oncology Institute, Inc. stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for The Oncology Institute, Inc. stock to perform well in the short-term.
Current score:
3.811
Buy Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on June 18, 2026 - $5.29 ( 0.771%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
TOI Performance
Trading levels for TOI
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 5.67 | 7.98% |
| R2 | 5.52 | 5.23% |
| R1 | 5.44 | 3.53% |
| Price | 5.25 | |
| S1 | 5.15 | -1.98% |
| S2 | 5.06 | -3.68% |
| S3 | 4.91 | -6.44% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 0 | - |
| R1 | 5.31 | 1.14% |
| Price | 5.25 | |
| S1 | 4.87 | -7.24% |
| S2 | 4.59 | -12.57% |
| S3 | 4.08 | -22.29% |
FAQ
Click here for our free guide on how to buy The Oncology Institute, Inc. Stock.
Buy TOI